NG2 knockdown in GBM xenografts increased vascular reabsorption, decreased plasma volume and normalized tumour vasculature. by Jian Wang (5901)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Image_2_Chemical Similarity of Co-occurring Trees Decreases With Precipitation and Temperature in North American Forests.jpg by Brian E. Sedio (10875330)

“…To test this prediction, we compared patterns of chemical and morphological trait diversity of 140 woody plant species among seven temperate forests in North America representing 16.2°C variation in mean annual temperature (MAT), 2,115 mm variation in mean annual precipitation (MAP), and from 10 to 68 co-occurring species. …”

Figure 2 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

CF-BECs demonstrate little change in viability after infection with PA at a dilution of 2 x 10² the OD 0.5 after 24 hours. by Meghan J. Hirsch (16528311)

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

Apigenin decrease eosinophil infiltration in colonic tissues from HFD-mice. by Daniela Gentile (5089280)

H₂ water decreased the accumulation of 8-oxoG in striatum after MPTP administration. by Kyota Fujita (258978)

Rdh10a deficient embryos have decreased RA signaling. by Enrico D’Aniello (798447)

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<i>(B)</i> When the antagonist is administrated twice, intraocular pressure remains low during 6 weeks (n = 10 each); the black arrow indicates the period of retinal and visual <i>in vivo</i> testing presented in <i>Fig. 6A,B</i>. <i>(C)</i> Dose-dependent effect of two administrations of CXCR3 antagonist on intraocular pressure as tested two weeks after the treatment (n = 5 each). * <i>P</i><0.05, ** <i>P</i><0.01. …”

PDGF-BB maintains Bcl2/Bax ratio and decreases caspase-3 activation induced by Tat and morphine. by Shaily Malik (226661)

“…(B) Densitometric analysis of the blots shown in (A). Tat and morphine together resulted in a significantly decreased ratio of Bcl2/Bax, indicating cell's progress towards apoptosis. …”

<i>Runx2-I^neo/neo</i> mice showed decreased bone density. by Hideaki Okura (632611)

Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

All Ca_V3.3 variants left-shift the voltage dependence of inactivation. by Yousra El Ghaleb (22075892)

Subjects:

RKIP inhibits breast cancer metastasis by decreasing MMP13 expression by targeting the Erk2 signaling pathway. by Ila Datar (433874)

Induction of a VSG synthesis block leads to a decrease in clearance of surface-bound anti-VSG221 antibodies. by Jackie L. Y. Cheung (3365033)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

OPN-deficiency decreases inflammation, oxidative stress and fibrosis in adipose tissue. by Andoni Lancha (335824)

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…<p>(A) Microarray gene expression analysis of postmortem dorsolateral PFC (DLPFC) samples collected from patients with PTSD shows decreased levels of SGK1 mRNA. …”